Role of
El papel de la PET/TC con
Chemoradiotherapy
Clinical Decision-Making
Combined Modality Therapy
Cost-Benefit Analysis
Diagnosis, Differential
Early Diagnosis
Fibrosis
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Humans
Lung Diseases
/ diagnosis
Lung Neoplasms
/ diagnostic imaging
Meta-Analysis as Topic
Neoplasm Metastasis
Neoplasm Recurrence, Local
/ diagnostic imaging
Neoplasm Staging
/ methods
Pneumonectomy
Positron Emission Tomography Computed Tomography
/ economics
Radiofrequency Ablation
Radiopharmaceuticals
Radiosurgery
Sensitivity and Specificity
Treatment Outcome
Cáncer de pulmón
Estadificación
FDG PET/CT
FDG PET/TC
Lung cancer
Monitoring treatment response
Monitorización de la respuesta al tratamiento
Prognostic value
Restadificación
Restaging
Staging
Valor pronóstico
Journal
Revista espanola de medicina nuclear e imagen molecular
ISSN: 2253-8089
Titre abrégé: Rev Esp Med Nucl Imagen Mol (Engl Ed)
Pays: Spain
ID NLM: 101770941
Informations de publication
Date de publication:
Historique:
received:
21
01
2019
revised:
04
02
2019
accepted:
06
02
2019
pubmed:
17
6
2019
medline:
25
1
2020
entrez:
17
6
2019
Statut:
ppublish
Résumé
Lung cancer is a fairly common malignancy. An early diagnosis and a reliable staging and re-staging with the aim to detect both local and distant relapse are of utmost importance in planning the therapeutic management. The imaging diagnostic work-up of patients with lung cancer usually includes conventional imaging (chest X-ray, contrast-enhanced CT, bone scan) and more recently
Identifiants
pubmed: 31202725
pii: S2253-654X(19)30017-4
doi: 10.1016/j.remn.2019.02.003
pii:
doi:
Substances chimiques
Fluorine Radioisotopes
0
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Fluorine-18
GZ5I74KB8G
Types de publication
Journal Article
Review
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
229-233Informations de copyright
Copyright © 2019 Sociedad Española de Medicina Nuclear e Imagen Molecular. Publicado por Elsevier España, S.L.U. All rights reserved.